P3 Health Partners INC Form 4 insider transactions

Hudson Vegas Investment SPV, LLC executed a redemption of 50,000 P3 LLC Units for Class A Common Stock.

P3 Health Partners CFO Leif Elliott Pedersen was granted 30,000 stock options with an exercise price of $3.5479.

P3 Health Partners Director Gregory D. Wasson filed an amended Form 4 to correct previously reported stock ownership and disclose a grant of 2,000 restricted stock units.

P3 Health Partners director Mary A. Tolan amends SEC filing to correct beneficial ownership post-reverse stock split and reports new RSU grant.

P3 Health Partners Inc. Director Lawrence B. Leisure filed an amended Form 4 to correct his beneficial ownership following a 1-for-50 reverse stock split.

P3 Health Partners Director Gregory N. Kazarian received a grant of 2,000 restricted stock units, with the filing also correcting his beneficial ownership post-reverse stock split.

P3 Health Partners Director Mark Thierer filed an amended Form 4 to correct his beneficial ownership, reflecting a reverse stock split and RSU grant.

P3 Health Partners Director Thomas Price amends beneficial ownership post-reverse stock split and receives a new restricted stock unit grant.

P3 Health Partners Inc. Director Jeffrey G. Park filed an amended Form 4 to correct his beneficial ownership of Class A Common Stock following a 1-for-50 reverse stock split and report a new RSU grant.

P3 Health Partners Director Gregory N. Kazarian was granted 2,000 restricted stock units, increasing his total beneficial ownership to 218,561 shares.

P3 Health Partners Inc. director Mary A. Tolan was granted 2,000 restricted stock units, vesting in one year.

P3 Health Partners Inc. director Mark Thierer was granted 4,000 restricted stock units, vesting in one year.

P3 Health Partners Inc. Director Gregory D. Wasson was granted 2,000 restricted stock units, aligning his interests with shareholders.

P3 Health Partners Inc. Director Jeffrey G. Park was granted 2,000 restricted stock units of Class A common stock, vesting in one year.

P3 Health Partners Inc. Director Lawrence B. Leisure was granted 2,000 restricted stock units, vesting in one year.

P3 Health Partners Inc. Director Thomas Edmunds Price was granted 2,000 restricted stock units vesting in one year.

P3 Health Partners Inc. has disclosed a financing transaction involving a $30 million promissory note and warrants for 1.43 million shares of Class A Common Stock, issued to VBC Growth SPV 4, LLC, an entity managed by affiliates of Chicago Pacific Founders, a 10% owner and director.

Chicago Pacific Founders has acquired warrants to purchase 71,406,480 shares of P3 Health Partners Class A Common Stock through a financing transaction.

Chicago Pacific Founders UGP III, LLC, along with related entities, increased its holdings in P3 Health Partners Inc. through open market purchases of Class A Common Stock.

Chicago Pacific Founders UGP III, LLC, along with affiliated entities, has increased its indirect ownership in P3 Health Partners Inc. (PIII) through a series of open market purchases.

Chicago Pacific Founders UGP III, LLC, along with related entities, has increased its holdings in P3 Health Partners Inc. (PIII) through a series of open market purchases between September 4th and September 6th, 2024.

Chicago Pacific Founders UGP III, LLC files an amended Form 4 to correct the purchase date of P3 Health Partners Inc. (PIII) stock.

Chicago Pacific Founders UGP III, LLC files an amended Form 4 to correct an omission of 90,000 shares in previous filings related to P3 Health Partners Inc. (PIII).

Chicago Pacific Founders UGP III, LLC files an amended Form 4 to correct an omission of 21,850 shares in previous filings related to P3 Health Partners Inc. (PIII).

Chicago Pacific Founders UGP III, LLC files an amended Form 4 to correct an omission of 157,416 shares in previous filings related to P3 Health Partners Inc. ownership.

Leavitt Equity Partners III, L.P. purchased 7,974,481 units of P3 Health Partners Inc. at $0.6270 per unit, consisting of one share of Class A Common Stock and one warrant.

Director Thomas Price of P3 Health Partners Inc. (PIII) was granted stock options for 482,640 shares at an exercise price of $0.5461 on June 6, 2024, according to a Form 4 filing.

Mark Thierer, a director of P3 Health Partners Inc., acquired 965,279 stock options on June 6, 2024, exercisable at $0.5461 per share.

Director Gregory Wasson acquired stock options in P3 Health Partners Inc. on June 6, 2024, according to a Form 4 filing with the SEC.

Director Mary Tolan acquired stock options in P3 Health Partners Inc. on June 6, 2024, according to a recent SEC Form 4 filing.